Drawing for BEHRING

USPTO serial 79003201

BEHRING

Reviewed by CopyMark Law Group

Reg. 3127022Status 706Renewal
Filing date
Status date
Registration date
Aug 8, 2006
Examiner
RIRIE, VERNA BETH
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with BEHRING?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $850

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Scott D. Woldow

Scott D. Woldow Smith, Gambrell & Russell, LLP1055 Thomas Jefferson Street, NWSuite 400Washington, DC 20007

Goods and services

ClassDescriptionStatusFirst use
005[ Diagnostic preparations and reagents for medical use; vaccines; ] pharmaceutical preparations for the treatment of hemophilia, blood coagulation disorders and immune system disorders; [ pharmaceutical preparations for the inhibition of blood clots; ] pharmaceutical preparations for promoting wound healing; and pharmaceutical preparations, namely, blood plasma expandersACTIVE—
010[ Diagnostic products for use in clinical laboratories, namely, diagnostic systems used to generate diagnostic test results and to measure and test blood and other biological samples, comprised of analyzers, computer hardware, software and documentation, all sold as a unit for coagulation, protein, infectious disease, immunochemistry, chemistry, nucleic diagnostic testing, cancer, fertility, diabetes, cardiac function, thyroid testing, testing for health related conditions, and microbiology testing; medical and clinical diagnostic analyzers for use in specimen testing, drug testing, specimen validity analysis, and for serum toxicology assays; Medical apparatus for clinical and medical diagnostic use, namely, sample tube conveyors for use in the automation of biological sample processing and analysis of information related thereto; and empty container cartridges for clinical laboratory medical use to contain diagnostic reagents ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 5, 2026INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 5, 2026NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Feb 5, 202671AGREGISTERED-SEC.71 ACCEPTED—
Jan 26, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 23, 2025ES71TEAS SECTION 71 RECEIVED—
Aug 8, 2025REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Feb 29, 2024RNWLINTERNATIONAL REGISTRATION RENEWED—
Aug 12, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 12, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 12, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 12, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 12, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 1, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 5, 2019CHLDCHANGE OF OWNER RECEIVED FROM IB—
May 23, 2017CORVREVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED—
Apr 7, 2017INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Apr 6, 2017INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 31, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 17, 2016NA15SEC. 15 ACKNOWLEDGEMENT - E-MAILED—
Aug 17, 201615AKREGISTERED - SEC. 15 ACKNOWLEDGED—
Aug 17, 2016PLGLASSIGNED TO PARALEGAL—
Aug 7, 2016NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Aug 6, 201671AGREGISTERED-SEC.71 ACCEPTED—
Aug 5, 2016APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 29, 2016ES71TEAS SECTION 71 RECEIVED—
Jun 29, 2016E15RTEAS SECTION 15 RECEIVED—
Feb 25, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 1, 2014INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Apr 1, 2014INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Feb 27, 2014RNWLINTERNATIONAL REGISTRATION RENEWED—
May 11, 2013INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 10, 2013NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 11, 2012NA71NOTICE OF ACCEPTANCE OF SEC. 71 - MAILED—
Sep 11, 201271.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Sep 11, 2012APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 7, 201271AFREGISTERED-SEC.71 FILED—
Aug 7, 2012ES71TEAS SECTION 71 RECEIVED—
Apr 18, 2008FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 4, 2007FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 4, 2007FIMPFINAL DISPOSITION PROCESSED—
Mar 27, 2007FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 2, 2006CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Sep 15, 2006CHLDCHANGE OF OWNER RECEIVED FROM IB—
Aug 8, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 16, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 26, 2006NPUBNOTICE OF PUBLICATION—
Mar 27, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 24, 2006ALIEASSIGNED TO LIE—
Mar 17, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 27, 2006TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 24, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 24, 2006TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 20, 2005CPRAPRIORITY ACTION MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Dec 19, 2005CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Nov 28, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Nov 14, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 14, 2005MAILPAPER RECEIVED—
Jun 2, 2005CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 2, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 25, 2005LIMSLIMITATION OF GOODS/SERVICES FROM IB ENTERED—
May 12, 2005CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Apr 11, 2005CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 8, 2005CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 2, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Feb 11, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 11, 2005MAILPAPER RECEIVED—
Oct 8, 2004RFNTREFUSAL PROCESSED BY IB—
Sep 10, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 6, 2004CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 2, 2004DOCKASSIGNED TO EXAMINER—
Jul 19, 2004NWAPNEW APPLICATION ENTERED—
Jul 15, 2004REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance